CXCR4 Over-Expression and Survival in Cancer: A System Review and Meta-Analysis

Oncotarget - United States
doi 10.18632/oncotarget.3217
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Metformin Use and Survival Outcomes in Endometrial Cancer: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2017English

Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis

Gastroenterology Research and Practice
HepatologyGastroenterology
2018English

Predictors of Survival in Progressive Supranuclear Palsy and Multiple System Atrophy: A Systematic Review and Meta-Analysis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2017English

The Urokinase Plasminogen Activation System in Gastroesophageal Cancer: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2017English

Meta-Analysis of Clodronate and Breast Cancer Survival

British Journal of Cancer
Cancer ResearchOncology
2007English

The Impact of Androgen Receptor Expression on Breast Cancer Survival: A Retrospective Study and Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

Survival Benefits of Metformin for Colorectal Cancer Patients With Diabetes: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Survival Benefits From Follow-Up of Patients With Lung Cancer: A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Metformin Use Improves Survival of Diabetic Liver Cancer Patients: Systematic Review and Meta-Analysis

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy